The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Timed-sequential therapy with mibefradil and temozolomide in patients with recurrent high-grade gliomas: A phase I Adult Brain Tumor Consortium study.
 
Matthias Holdhoff
Research Funding - Bristol-Myers Squibb; Celldex
 
Xiaobu Ye
No Relationships to Disclose
 
Louis B. Nabors
Consulting or Advisory Role - Merck KGaA
Travel, Accommodations, Expenses - Merck KGaA
 
Arati Suvas Desai
No Relationships to Disclose
 
Tom Mikkelsen
Honoraria - Roche/Genentech
Consulting or Advisory Role - Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Glenn Lesser
Honoraria - Merck
Consulting or Advisory Role - Abbvie; Stemline Therapeutics
Research Funding - Celldex; ImmunoCellular Therapeutics; Northwest Biotherapeutics
 
William L. Read
No Relationships to Disclose
 
Frank S. Lieberman
No Relationships to Disclose
 
Jeff Supko
Employment - Sanofi (I)
Consulting or Advisory Role - Debiopharm Group; Millennium
 
Joy D. Fisher
No Relationships to Disclose
 
Serena Desideri
No Relationships to Disclose
 
Stuart A. Grossman
Stock and Other Ownership Interests - Axxia Pharmaceuticals
Honoraria - MedImmune; Roche/Genentech
Consulting or Advisory Role - Midatech Pharma
Research Funding - Erimos Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Patent related to a subcutaneous polymeric opioid delivery system have been awarded.
 
David Schiff
Consulting or Advisory Role - Cavion (Inst)